La catena delle opzioni mostra i dati chiave delle opzioni azionarie di PepGen a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per PepGen..

PepGen (NASDAQ:PEPG) Azioni, Catena delle Opzioni

PepGen

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

PepGen Inc

News

Aspira Women's Health Expands Its Co-Marketing And Distribution Collaboration With BioReference To Include OvaWatch

Guidance

Warner Bros Discovery Said It Will Launch Max Streaming Service In Seven Markets In Southeast Asia; Will Launch In Australia Next Year -Conf Call

WIIM

BYND

Beyond Meat shares are trading lower after the company announced it filed to sell common stock for up to $20 million.

New hardware boasts significant improvements to reduce noise and generate higher fidelity signals
PLEASANTON, Calif., Nov. 7, 2024 /PRNewswire/ -- Movano Health Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) announced today that it has tested its newly developed blood pressure wrist wearable as part of its November 5th and 6th&nbsp;hypoxia clinical trial that took place at the University of California, San Francisco. The updated device features an additional 12 mmWave antennas which together with Movano Health's custom IC delivers enhanced data collection with less impact of placement while also featuring a slimmer design, making it easier and more comfortable to wear. In addition, the new wearable monitors a host of other vital signs including pulse rate, blood oxygen saturation (Sp02), respiration rate and ECG waveforms.

Biotech

General

MOVE

Movano Health Announces Completion Of Clinical Study With Cuffless RF Blood Pressure Device

Tegna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGNA#NYSE">TGNA</a>) reported quarterly earnings of $0.94 per share which beat the analyst consensus estimate of $0.86 by 9.3 percent. The company reported quarterly sales of $806.83 million which beat the analyst consensus estimate of $794.42 million by 1.56 percent. This is a 13.12 percent increase over sales of $713.24 million the same period last year.

Earnings

Earnings Beats

TGNA

Tegna Q3 2024 Adj EPS $0.94 Beats $0.86 Estimate, Sales $806.83M Beat $794.42M Estimate

TGLS

Tecnoglass Revises FY24 Revenue Outlook From $860M -$910M To  $880M -$900M, Est $889.74M

Rallybio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLYB#NASDAQ">RLYB</a>) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.37) by 29.73 percent. This is a 42.22 percent increase over losses of $(0.45) per share from the same period last year. The company reported $299.00 thousand in sales this quarter.

RLYB

Rallybio Q3 EPS $(0.26) Beats $(0.37) Estimate, Sales $299.00K

Politics

Unilever, Procter & Gamble Face Risk From Trump's Threatened Mexico Tariffs

Airgain's AT-Flight Asset Tracker device is cellular enabled and in-flight certified to allow for full journey tracking.
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.airgain.com%2F&amp;esheet=54148176&amp;newsitemid=20241107723078&amp;lan=en-US&amp;anchor=Airgain%2C+Inc.+%28NASDAQ%3A+AIRG%29&amp;index=1&amp;md5=246dc5f4a3ea39a3c96a57f007bc412d">Airgain, Inc. (NASDAQ:</a><a href="https://www.benzinga.com/stock/AIRG#NASDAQ">AIRG</a>), a leading provider of wireless connectivity solutions, has released the AT-Flight asset tracker, targeting the healthcare and life sciences IoT markets.
This press release features multimedia. View the full release here: <a href="https://www.businesswire.com/news/home/20241107723078/en/">https://www.businesswire.com/news/home/20241107723078/en/</a>
Designed for high-value, temperature-sensitive assets, the AT-Flight offers an ideal solution for real-time tracking across ground and air transportation, ensuring compliance and operational efficiency in cold chain logistics and other critical healthcare applications.
The AT-Flight combines advanced artificial intelligence with ambient sensor technology to automatically detect a flight event and activate airplane mode to comply with FAA regulations — eliminating the need for manual intervention.

AIRG

Airgain Launches Its First Integrated AI AT-Flight Asset Tracking Solution, Targeting The Healthcare And Life Sciences IoT Markets

Village Farms International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) reported its financial results Thursday for the third quarter ended Sep. 30, 2024. The British Columbia-based cannabis company disclosed revenue of $83.37 million, compared to $69.51 million in the same period a year ago.
"Strong performance in our fresh produce business, continued growth in Canadian cannabis and a doubling of international medicinal cannabis sales drove 20% year-over-year growth in consolidated sales, with both positive Adjusted EBITDA and cash flow from operations during the third quarter," stated Michael DeGiglio, president and CEO. "Our Canadian cannabis business continues to deliver strong growth with leading market share as we realized revenue growth in all sales channels and positive EBITDA and operating cash flow. We were once again the fastest growing producer in Canada over the last year in terms of market share and, for the first time ever, were number one in Quebec, making us the top producer in Canada's two most populus provinces."
 Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/41792417/cannabis-reit-giant-iipr-reports-q3-39-7m-profit-despite-rent-delays-in-sector">Cannabis REIT Giant IIPR Reports Q3 $39.7M Profit Despite Rent Delays In Sector</a>
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
<h2 class="wp-block-heading">Q3 Financial Highlights</h2>
<ul>
<li>Gross profit was $15.71 million, compared to $14.62 million in the same quarter last year.</li>
</ul>
<ul>
<li>Net loss was $800,000 or $0.01 per share, compared to loss of $1.3 million or $0.01 per share in the third quarter of 2023</li>
<li>Adjusted EBITDA was $5.3 million, compared to $3.25 million in the same period last year.</li>
<li>Consolidated cash flow from operations was $4.3 million compared with $12.1 million in the corresponding quarter of 2023.</li>
</ul>
DeGiglio added that the company continued sales increases to its German, Australian and UK partners and that its Dutch business has "the potential to become a strong contributor of profitability and cash flow generation, driven by more favorable pricing and taxes in the Dutch market compared to Canada."
<h2 class="wp-block-heading">Price Action</h2>
Village Farms shares closed Wednesday's market session 11.02% lower at 80 cents per share.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/11/41793174/cannabis-stocks-collapse-after-trump-win-major-players-see-double-digit-declines-at-wednesdays-c">Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday&#8217;s Close</a></li>
</ul>
Photo: Courtesy of&nbsp;HTWE&nbsp;via Shutterstock&nbsp;

Cannabis

Village Farms Quarterly Revenue Grows 20% YoY As The Cannabis Company Doubles International Sales

Legal

CPRI

Tapestry's CEO Said U.S. Judge's Decision To Block The Capri Deal Is Incorrect On Law, Facts; Confirmed They Have Appealed Decision, As Required By Merger Agreement -Conf Call

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Farcher.com%2F&amp;esheet=54148628&amp;newsitemid=20241107033638&amp;lan=en-US&amp;anchor=Archer+Aviation+Inc.&amp;index=1&amp;md5=7b557990d098d45c85a463f728f06dec">Archer Aviation Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>) and Soracle Corporation (Soracle), a joint venture newly established by Japan Airlines and Sumitomo Corporation, signed agreements focused on bringing advanced air mobility (AAM) services to Japan.
&nbsp;
Soracle plans to launch its AAM operation in Japan using Archer's <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Farcher.com%2Faircraft&amp;esheet=54148628&amp;newsitemid=20241107033638&amp;lan=en-US&amp;anchor=Midnight&amp;index=2&amp;md5=8aa347ea8b40f05cbc6f494120a7c6ec">Midnight</a> aircraft, with the goal of offering electric air taxi flights in cities where existing ground transportation is constrained by traffic or geographic barriers.
To do so, Soracle has obtained the right to place aircraft orders of up to 100 Midnight aircraft, totaling approximately $500M, which would include pre-delivery payments based on certain milestones in advance of aircraft delivery.
Soracle will develop a variety of flight routes in attractive areas for residents as well as domestic and international visitors. Route locations could include places like Tokyo, Osaka, Nagoya, Hokkaido, Setouchi and Okinawa with the aim of establishing a transportation network that creates new value through mobility in the sky.
Archer and Soracle will work closely with the Japanese Civil Aviation Bureau (JCAB) to obtain the necessary permissions and certifications. Archer and JCAB have already begun discussions and Archer intends to work to certify our aircraft in Japan.
To memorialize this joint agreement, Soracle and Archer held a signing ceremony in Tokyo on September 26, 2024.

Global

ACHR

Archer Aviation And Soracle, A Joint Venture Newly Established By Japan Airlines And Sumitomo Corporation, Signed Agreements Focused On Bringing Advanced Air Mobility Services To Japan; Soracle Has Obtained The Right To Place Aircraft Orders Of Up To 100 Midnight Aircraft, Totaling ~$500M

Dividends

Regency Centers Increases Quarterly Dividend From $0.67 To $0.705 Per Share

Ralph Lauren shares are trading higher after the company reported better-than-expected Q2 financial results.

During the quarter, the Company made a $17.5 million voluntary prepayment to its syndicate term loan facility. The Company ended the quarter with approximately $26.5 million remaining under the current share repurchasing program.

Buybacks

Tecnoglass Expands Share Repurchase Program To $100M

CTVA

Corteva shares are trading lower after the company reported worse-than-expected Q3 financial results and issued FY24 sales guidance with its midpoint below estimates.

HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintains Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) with a Buy and raises the price target from $64 to $69.

Price Target

Analyst Ratings

RYTM

HC Wainwright & Co. Maintains Buy on Rhythm Pharmaceuticals, Raises Price Target to $69

PepGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEPG#NASDAQ">PEPG</a>) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.87) by 24.14 percent. This is a 32.65 percent increase over losses of $(0.98) per share from the same period last year.

PEPG

PepGen Q3 EPS $(0.66) Beats $(0.87) Estimate

Tecnoglass Board Approves 36% Increase In Quarterly Dividend From $0.11 To $0.15 Per Share

Health Care

ENSC

Ensysce Biosciences Has Received Notice From The Nasdaq Stock Market That The Company May Continue Its Listing On The Nasdaq Capital Market Tier With An Extension To November 14

PepGen: EDOs Could Enhance Dystrophin Expression Beyond Scope Of Current Treatments

Leerink Partners analyst Joseph Schwartz has reiterated their bullish stance on PEPG stock, giving a Buy rating yesterday. Joseph Schwartz has give...

Optimistic Outlook on PepGen's DMD Therapy Despite Initial Data: Analyst Reiterates Buy Rating

REGENXBIO releases new data on DMD drug ahead of earnings

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
PepGen (NASDAQ:<a href="https://investorplace.com/stock-quotes/pepg-stock-quote/">PEPG</a>) just reported results for the second quarter of 2024.<ul><li>PepGen reported earnings per share of -87 cents. This was below the analyst estimate for EPS of -72 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/pepg-stock-earnings-pepgen-for-q2-of-2024/">PEPG Stock Earnings: PepGen Misses EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

PEPG Stock Earnings: PepGen Misses EPS for Q2 2024

PepGen GAAP EPS of -$0.87

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Kura Oncology (KURA – Research Report), Tenaya Thera...

Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Tenaya Therapeutics (TNYA) and PepGen Inc. (PEPG)

Dyne stock tumbles 31% amid drug updates, management changes

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2024 Update

PepGen Inc. ( ($PEPG) ) has shared an announcement. Christopher Ashton, Ph.D., has announced his intention to retire from the Board of Directors of...

PepGen Inc. Board Reshuffles as Ashton Plans Retirement

Avidity gets FDA partial clinical hold lifted on DM1 drug candidate

AAPL

ACHC

ADBE

ADPT

AMZN

AVGO

BBIO

BMRN

CAPR

CPRX

DASH

DDOG

DLTR

EWTX

FDMT

FERG

INBX

KURA

LBPH

MSCLF

MSFT

NAMS

NFLX

ORIC

PHVS

RGNX

RHHBY

ROIV

RPRX

SLDB

SRPT

TMUS

TNYA

TRDA

TRVI

TTWO

VKTX

VRTX

WDAY

Press Releases

PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

PepGen Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

PepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & Development

PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & Development

PepGen Announces Christopher Ashton, PhD, to Retire from its Board of Directors

PepGen Announces Presentations at the 29th Annual Congress of the World Muscle Society

PepGen to Participate in Upcoming Investor Conferences

PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share

Comments

PepGen

PepGen (PEPG) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO